251 related articles for article (PubMed ID: 20426757)
1. Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.
Mahajan SD; Roy I; Xu G; Yong KT; Ding H; Aalinkeel R; Reynolds J; Sykes D; Nair BB; Lin EY; Prasad PN; Schwartz SA
Curr HIV Res; 2010 Jul; 8(5):396-404. PubMed ID: 20426757
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-mediated targeted delivery of antiretrovirals to the brain.
Mahajan SD; Law WC; Aalinkeel R; Reynolds J; Nair BB; Yong KT; Roy I; Prasad PN; Schwartz SA
Methods Enzymol; 2012; 509():41-60. PubMed ID: 22568900
[TBL] [Abstract][Full Text] [Related]
3. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain.
Kuo YC; Wang CC
Biotechnol Prog; 2014; 30(1):198-206. PubMed ID: 24167123
[TBL] [Abstract][Full Text] [Related]
4. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Kuo YC; Su FL
Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
[TBL] [Abstract][Full Text] [Related]
5. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
Viruses; 2020 May; 12(5):. PubMed ID: 32443728
[TBL] [Abstract][Full Text] [Related]
6. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
Kuo YC; Lee CL
Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
[TBL] [Abstract][Full Text] [Related]
7. Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir.
Roy U; Bulot C; Honer zu Bentrup K; Mondal D
PLoS One; 2013; 8(10):e75374. PubMed ID: 24098380
[TBL] [Abstract][Full Text] [Related]
8. Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages.
Gong Y; Chowdhury P; Nagesh PKB; Rahman MA; Zhi K; Yallapu MM; Kumar S
Sci Rep; 2020 Mar; 10(1):3835. PubMed ID: 32123217
[TBL] [Abstract][Full Text] [Related]
9. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Kuo YC; Yu HW
Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
[TBL] [Abstract][Full Text] [Related]
10. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Kuo YC; Kuo CY
Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
[TBL] [Abstract][Full Text] [Related]
12. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
Kanmogne GD; Singh S; Roy U; Liu X; McMillan J; Gorantla S; Balkundi S; Smith N; Alnouti Y; Gautam N; Zhou Y; Poluektova L; Kabanov A; Bronich T; Gendelman HE
Int J Nanomedicine; 2012; 7():2373-88. PubMed ID: 22661891
[TBL] [Abstract][Full Text] [Related]
13. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
14. Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood-brain barrier.
Yan F; Wang Y; He S; Ku S; Gu W; Ye L
J Mater Sci Mater Med; 2013 Oct; 24(10):2371-9. PubMed ID: 23793566
[TBL] [Abstract][Full Text] [Related]
15. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
17. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier and neuro-AIDS.
Zhang YL; Ouyang YB; Liu LG; Chen DX
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4927-39. PubMed ID: 26744885
[TBL] [Abstract][Full Text] [Related]
19. Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice.
Fiandra L; Colombo M; Mazzucchelli S; Truffi M; Santini B; Allevi R; Nebuloni M; Capetti A; Rizzardini G; Prosperi D; Corsi F
Nanomedicine; 2015 Aug; 11(6):1387-97. PubMed ID: 25839392
[TBL] [Abstract][Full Text] [Related]
20. In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents.
Glynn SL; Yazdanian M
J Pharm Sci; 1998 Mar; 87(3):306-10. PubMed ID: 9523983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
